Scientific studies paint a surprising picture - all but one of these supplements failed to prove their worth
Limited data exist regarding tirzepatide's effects on other inflammatory markers such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-) in humans, with most evidence coming from preclinical studies
Present in KLOW at 10mg, it is researched for actin sequestration, endothelial cell migration, angiogenesis support, and anti-inflammatory modulation in preclinical models
Modify protocols according to clinical response and lab trends, taper or cease peptides if insulin dysregulation, abnormal bleeding or pregnancy
Johnson CM, Wilson DM, OFallon WM et al (1979) Renal stone epidemiology: a 25-year study in Rochester, Minnesota